Gout and Hyperuricaemia Prevention
Gout and Hyperuricaemia Prevention
This page is deliberately narrow. Gout cannot be prevented by a diet, a supplement or a detox, and any page claiming otherwise is selling something. What is preventable is more specific and more valuable: the attacks, the joint damage, the kidney consequences, and part of the level. That is what follows — who should be tested, what genuinely moves the number, the medicines question, and what a long-term plan contains.
What prevention honestly means here
Three things are preventable, and it is worth separating them because they are usually blurred together.
The attacks. This is the most preventable item in the condition, and the mechanism is straightforward. Hold the urate level below saturation continuously and crystals stop forming and existing ones dissolve; the attacks stop. The treatment is long-term and the first months are covered by prophylaxis precisely because mobilising crystals can provoke attacks before it prevents them.
The damage. Erosions and tophi are consequences of years rather than inevitabilities, and they are the reason treatment is aimed at the level rather than at each attack. A person treated early, whose level has been below target for years, does not accumulate them. This is the argument for starting urate-lowering therapy rather than waiting until attacks are frequent.
Part of the level. Weight, alcohol, fructose-sweetened drinks, hydration and the medicines review each move the number measurably, though none of them by the amount a medicine achieves. Kidney handling and genes set the rest.
And one thing is not reversible: joint already eroded does not come back, and advanced tophaceous deposits shrink only slowly and incompletely. Stating that plainly is what makes the rest of this page worth reading, because everything below is aimed at what remains.
Who should be tested, and what the test is
Testing is aimed at the groups in which a raised level is common enough and consequential enough to be worth finding. That means anyone with a family history of gout, anyone taking a thiazide or loop diuretic or ciclosporin long-term, anyone with reduced kidney function, anyone with metabolic syndrome, anyone who has passed a kidney stone, and anyone with psoriasis or a myeloproliferative condition.
The test is a blood urate measurement, and it is usually already included in a metabolic panel. The important detail is when it is taken: during or in the weeks after an acute attack the level can be normal, so a measurement taken at the worst moment is the least reliable one. Where a first result is abnormal, it is repeated when the joint has been quiet for a few weeks.
A kidney function test belongs in the same sample, and so does a metabolic panel the first time — blood pressure, glucose, lipids. The reason is that the conditions found alongside a raised urate carry more long-term risk than the joint does, and finding them early is often the more valuable outcome of the whole exercise.
What moves the level, and by how much
The list is short and specific, and it is worth giving in order of effect rather than alphabetically. None of these replaces medicine; all of them make the medicine's job smaller.
| Measure | What it protects against | How much it asks |
|---|---|---|
| Water, enough to keep urine dilute | Concentrated urine, urate crystallisation and stone formation | The cheapest and least demanding item on the page, and one of the more effective |
| Cutting fructose-sweetened drinks | The clearest dietary effect on urate there is | A single substitution, and the largest dietary lever available |
| Reducing alcohol, particularly beer and spirits | Both the level and the frequency of attacks | Frequency and pattern matter; the binge does more harm than the steady drink |
| Steady weight loss where weight is the issue | Insulin resistance, which is what reduces urate excretion | Gradual. Crash dieting raises urate and can trigger an attack — worth warning in advance |
| Moderating the largest purine loads | The acute rise after a heavy meat, offal or seafood meal | Portion and frequency rather than exclusion; the effect is real but smaller than reputed |
Two closing points. Supplements and "joint health" products are not preventive treatment, and some interact with the medicines used here. And the dietary items above act on the level, not on the joint — an attack in progress is treated as inflammation, whatever the diet has been.
The medicines question, and what to ask about
Medicines are both the most effective protection in this condition and one of its commonest causes, and the same conversation covers both.
On the protective side: urate-lowering therapy is taken every day whether or not the joint hurts, because its work happens between attacks. The two mistakes are symmetrical and both common — stopping it when the attacks stop, and stopping it during an attack. The first lets the level climb back silently; the second produces the cluster of flares that convinces people the medicine is the problem.
On the harmful side: the group most often responsible is diuretics — thiazide and loop diuretics prescribed for blood pressure or heart failure — followed by low-dose aspirin, ciclosporin and the anti-tuberculosis medicines pyrazinamide and ethambutol. None of these should be stopped independently; all of them should be raised with whoever prescribed them, because a substitute is often available.
What to do about it is simple and worth doing once, properly: keep a written list of everything taken, including supplements and anything bought without a prescription; take it to every appointment; and ask specifically whether each item affects urate. That question is answerable in a minute and it is one of the higher-yield things a patient can do.
What a long-term plan contains
The plan exists because this is a condition managed over years, and because the sequence — level down in weeks, attacks stop over months, tophi shrink over years — is easier to stay with when it has been written down in advance.
What is measured, and how often — serum urate at intervals during titration until the target is reached, then periodically to confirm it is being held; kidney function alongside it; and the metabolic panel at least annually.
What each result would trigger — a level above target means the dose is increased rather than the medicine abandoned; a rising creatinine means the dose and the drug choice are revisited; a breakthrough attack means prophylaxis is reviewed, not that urate lowering is stopped.
What happens during illness — fluids, and a note of which medicines to pause during vomiting or diarrhoea. Dehydration is one of the commonest triggers, and the plan is written before it is needed.
What the timeline looks like — stated at the beginning: weeks to reach target, months for attacks to stop, years for tophi to resolve. Patients who know this stay on treatment; patients who are not told abandon it in month two, when the medicine appears to be causing attacks rather than preventing them.